vs

Side-by-side financial comparison of ONE Group Hospitality, Inc. (STKS) and VERACYTE, INC. (VCYT). Click either name above to swap in a different company.

ONE Group Hospitality, Inc. is the larger business by last-quarter revenue ($207.0M vs $140.6M, roughly 1.5× VERACYTE, INC.). VERACYTE, INC. runs the higher net margin — 29.3% vs -3.1%, a 32.3% gap on every dollar of revenue. On growth, VERACYTE, INC. posted the faster year-over-year revenue change (18.5% vs -6.7%). VERACYTE, INC. produced more free cash flow last quarter ($48.8M vs $-329.0K). Over the past eight quarters, ONE Group Hospitality, Inc.'s revenue compounded faster (56.1% CAGR vs 20.5%).

Target Hospitality is a company that provides workforce lodging and other temporary, modular housing used for oil, gas and mining operations; large-scale events; and disaster relief. Target Hospitality is based in The Woodlands, Texas, and also has offices in Williston, North Dakota; Denver, Colorado; Calgary, Alberta.

Veracyte Inc. is a leading molecular diagnostics company that develops and commercializes proprietary genomic testing solutions for early, accurate detection of cancer and other complex diseases. Its offerings help healthcare providers make better clinical decisions to improve patient outcomes, with core operations in the U.S. and expanding global market presence across key clinical segments.

STKS vs VCYT — Head-to-Head

Bigger by revenue
STKS
STKS
1.5× larger
STKS
$207.0M
$140.6M
VCYT
Growing faster (revenue YoY)
VCYT
VCYT
+25.2% gap
VCYT
18.5%
-6.7%
STKS
Higher net margin
VCYT
VCYT
32.3% more per $
VCYT
29.3%
-3.1%
STKS
More free cash flow
VCYT
VCYT
$49.1M more FCF
VCYT
$48.8M
$-329.0K
STKS
Faster 2-yr revenue CAGR
STKS
STKS
Annualised
STKS
56.1%
20.5%
VCYT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
STKS
STKS
VCYT
VCYT
Revenue
$207.0M
$140.6M
Net Profit
$-6.4M
$41.1M
Gross Margin
72.5%
Operating Margin
2.2%
26.4%
Net Margin
-3.1%
29.3%
Revenue YoY
-6.7%
18.5%
Net Profit YoY
-531.8%
704.8%
EPS (diluted)
$-0.50
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STKS
STKS
VCYT
VCYT
Q4 25
$207.0M
$140.6M
Q3 25
$180.2M
$131.9M
Q2 25
$207.4M
$130.2M
Q1 25
$211.1M
$114.5M
Q4 24
$221.9M
$118.6M
Q3 24
$194.0M
$115.9M
Q2 24
$172.5M
$114.4M
Q1 24
$85.0M
$96.8M
Net Profit
STKS
STKS
VCYT
VCYT
Q4 25
$-6.4M
$41.1M
Q3 25
$-76.7M
$19.1M
Q2 25
$-10.1M
$-980.0K
Q1 25
$975.0K
$7.0M
Q4 24
$1.5M
$5.1M
Q3 24
$-9.3M
$15.2M
Q2 24
$-7.3M
$5.7M
Q1 24
$-2.1M
$-1.9M
Gross Margin
STKS
STKS
VCYT
VCYT
Q4 25
72.5%
Q3 25
69.2%
Q2 25
69.0%
Q1 25
69.5%
Q4 24
66.4%
Q3 24
68.2%
Q2 24
68.1%
Q1 24
64.5%
Operating Margin
STKS
STKS
VCYT
VCYT
Q4 25
2.2%
26.4%
Q3 25
-4.4%
17.4%
Q2 25
0.3%
-4.0%
Q1 25
5.1%
2.5%
Q4 24
5.5%
3.5%
Q3 24
-1.9%
10.4%
Q2 24
0.6%
4.0%
Q1 24
-0.7%
-4.8%
Net Margin
STKS
STKS
VCYT
VCYT
Q4 25
-3.1%
29.3%
Q3 25
-42.6%
14.5%
Q2 25
-4.9%
-0.8%
Q1 25
0.5%
6.2%
Q4 24
0.7%
4.3%
Q3 24
-4.8%
13.1%
Q2 24
-4.3%
5.0%
Q1 24
-2.4%
-1.9%
EPS (diluted)
STKS
STKS
VCYT
VCYT
Q4 25
$-0.50
$0.50
Q3 25
$-2.75
$0.24
Q2 25
$-0.59
$-0.01
Q1 25
$-0.21
$0.09
Q4 24
$-0.18
$0.07
Q3 24
$-0.53
$0.19
Q2 24
$-0.38
$0.07
Q1 24
$-0.07
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STKS
STKS
VCYT
VCYT
Cash + ST InvestmentsLiquidity on hand
$4.2M
$362.6M
Total DebtLower is stronger
$354.2M
Stockholders' EquityBook value
$-75.8M
$1.3B
Total Assets
$884.2M
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STKS
STKS
VCYT
VCYT
Q4 25
$4.2M
$362.6M
Q3 25
$5.5M
$315.6M
Q2 25
$4.7M
$219.5M
Q1 25
$21.4M
$186.1M
Q4 24
$27.6M
$239.1M
Q3 24
$28.2M
$274.1M
Q2 24
$32.2M
$235.9M
Q1 24
$15.4M
$209.2M
Total Debt
STKS
STKS
VCYT
VCYT
Q4 25
$354.2M
Q3 25
$355.0M
Q2 25
$347.4M
Q1 25
$348.3M
Q4 24
$348.3M
Q3 24
$349.1M
Q2 24
$350.0M
Q1 24
$73.5M
Stockholders' Equity
STKS
STKS
VCYT
VCYT
Q4 25
$-75.8M
$1.3B
Q3 25
$-61.5M
$1.3B
Q2 25
$23.0M
$1.2B
Q1 25
$40.5M
$1.2B
Q4 24
$45.9M
$1.2B
Q3 24
$51.4M
$1.2B
Q2 24
$68.1M
$1.1B
Q1 24
$68.3M
$1.1B
Total Assets
STKS
STKS
VCYT
VCYT
Q4 25
$884.2M
$1.4B
Q3 25
$879.5M
$1.4B
Q2 25
$935.7M
$1.3B
Q1 25
$956.0M
$1.3B
Q4 24
$960.1M
$1.3B
Q3 24
$953.5M
$1.3B
Q2 24
$945.9M
$1.2B
Q1 24
$309.3M
$1.2B
Debt / Equity
STKS
STKS
VCYT
VCYT
Q4 25
Q3 25
Q2 25
15.07×
Q1 25
8.61×
Q4 24
7.59×
Q3 24
6.79×
Q2 24
5.14×
Q1 24
1.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STKS
STKS
VCYT
VCYT
Operating Cash FlowLast quarter
$13.1M
$52.6M
Free Cash FlowOCF − Capex
$-329.0K
$48.8M
FCF MarginFCF / Revenue
-0.2%
34.7%
Capex IntensityCapex / Revenue
6.5%
2.7%
Cash ConversionOCF / Net Profit
1.28×
TTM Free Cash FlowTrailing 4 quarters
$-27.3M
$126.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STKS
STKS
VCYT
VCYT
Q4 25
$13.1M
$52.6M
Q3 25
$5.9M
$44.8M
Q2 25
$2.8M
$33.6M
Q1 25
$8.5M
$5.4M
Q4 24
$18.5M
$24.5M
Q3 24
$19.1M
$30.0M
Q2 24
$-3.8M
$29.6M
Q1 24
$10.4M
$-9.0M
Free Cash Flow
STKS
STKS
VCYT
VCYT
Q4 25
$-329.0K
$48.8M
Q3 25
$-6.1M
$42.0M
Q2 25
$-15.0M
$32.3M
Q1 25
$-5.8M
$3.5M
Q4 24
$733.0K
$20.4M
Q3 24
$287.0K
$27.7M
Q2 24
$-23.0M
$26.8M
Q1 24
$-5.4M
$-11.1M
FCF Margin
STKS
STKS
VCYT
VCYT
Q4 25
-0.2%
34.7%
Q3 25
-3.4%
31.8%
Q2 25
-7.2%
24.8%
Q1 25
-2.7%
3.1%
Q4 24
0.3%
17.2%
Q3 24
0.1%
23.9%
Q2 24
-13.3%
23.4%
Q1 24
-6.4%
-11.5%
Capex Intensity
STKS
STKS
VCYT
VCYT
Q4 25
6.5%
2.7%
Q3 25
6.7%
2.1%
Q2 25
8.6%
1.0%
Q1 25
6.8%
1.6%
Q4 24
8.0%
3.5%
Q3 24
9.7%
1.9%
Q2 24
11.1%
2.4%
Q1 24
18.6%
2.2%
Cash Conversion
STKS
STKS
VCYT
VCYT
Q4 25
1.28×
Q3 25
2.34×
Q2 25
Q1 25
8.76×
0.76×
Q4 24
12.54×
4.80×
Q3 24
1.98×
Q2 24
5.16×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

STKS
STKS

Benihanas$111.3M54%
Steakhouse Restaurant$59.2M29%
Grill Concepts$32.3M16%
Other$4.2M2%

VCYT
VCYT

Testing$135.8M97%
Products$3.8M3%
Biopharmaceutical And Other$686.0K0%

Related Comparisons